These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 11344629

  • 1. [Monitoring minimal residual disease in patients with hairy cell leukemia in complete remission after treatment with 2-chlorodioxyadenosine].
    Zák P, Chrobák L, Dĕdic K, Podzimek K.
    Vnitr Lek; 2000 Oct; 46(10):697-703. PubMed ID: 11344629
    [Abstract] [Full Text] [Related]

  • 2. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
    Konwalinka G, Schirmer M, Hilbe W, Fend F, Geisen F, Knoblechner A, Petzer A, Thaler J.
    Blood Cells Mol Dis; 1995 Oct; 21(2):142-51. PubMed ID: 8846043
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O, Tomová A, Kusenda J, Gyárfás J.
    Neoplasma; 2001 Oct; 48(5):350-7. PubMed ID: 11845978
    [Abstract] [Full Text] [Related]

  • 5. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
    Urasiński I, Zdziarska B, Krygier-Stojałowska A.
    Acta Haematol Pol; 1996 Oct; 27(1):49-55. PubMed ID: 8629443
    [Abstract] [Full Text] [Related]

  • 6. Cladribine in hairy cell leukemia.
    Belani R, Saven A.
    Hematol Oncol Clin North Am; 2006 Oct; 20(5):1109-23. PubMed ID: 16990111
    [Abstract] [Full Text] [Related]

  • 7. [Hairy cell leukemia. An alternative method for the detection of minimal residual disease using flow cytometry].
    Bengio R, Narbaitz M, Palacios F, Scolnik M, Sarmiento M.
    Medicina (B Aires); 2000 Oct; 60 Suppl 2():71-6. PubMed ID: 11188936
    [Abstract] [Full Text] [Related]

  • 8. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
    Rucińska M, Machaczka M, Załuska A, Skotnicki AB.
    Przegl Lek; 1998 Oct; 55(7-8):400-6. PubMed ID: 10021885
    [Abstract] [Full Text] [Related]

  • 9. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M, Rolović Z, Radosević N, Draguljac N, Jovanović V, Bogdanović A, Bosković D.
    Srp Arh Celok Lek; 2000 Oct; 128(7-8):262-70. PubMed ID: 11089434
    [Abstract] [Full Text] [Related]

  • 10. Rituximab as treatment for minimal residual disease in hairy cell leukaemia.
    Cervetti G, Galimberti S, Andreazzoli F, Fazzi R, Cecconi N, Caracciolo F, Petrini M.
    Eur J Haematol; 2004 Dec; 73(6):412-7. PubMed ID: 15522063
    [Abstract] [Full Text] [Related]

  • 11. Dyserythropoietic changes and sideroblastic anemia in patients with hairy cell leukemia before and after therapy with 2-chlorodeoxyadenosine.
    Zák P, Chrobák L, Podzimek K, Plísková L, Dedic K.
    Neoplasma; 1998 Dec; 45(4):261-5. PubMed ID: 9890671
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Immunohistochemical detection and quantification of minimal residual disease using DBA.44 antibodies in trephination biopsies of hairy cell leukemia].
    Dĕdic K, Zák P.
    Cesk Patol; 2003 Oct; 39(4):175-7. PubMed ID: 14663929
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W, Weltermann A, Chott A, Gisslinger H, Valent P, Jäger U, Geissler K, Lechner K.
    Wien Klin Wochenschr; 1999 Dec 23; 111(24):1027-30. PubMed ID: 10677889
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Use of image analysis and immunostaining of bone marrow trephine biopsy specimens to quantify residual disease in patients with B-cell chronic lymphocytic leukemia.
    Gala JL, Guiot Y, Delannoy A, Scheiff JM, Philippe M, Martiat P.
    Mod Pathol; 1999 Apr 23; 12(4):391-9. PubMed ID: 10229504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.